A team at GSK has identified what could be an entirely new weapon in the fight to eradicate malaria – but it isn't a new vaccine or antimalarial compound.
After months of deliberations, the National Institute of Allergy and Infectious Diseases (NIAID) has a new director to replace Dr Anthony Fauci, who held the role for 38 y
GSK has filed a lawsuit against Pfizer in a US court alleging infringement of patents that it holds on vaccines against respiratory syncytial virus (RSV).
More than 1.5 billion people around the world are infected with soil-transmitted helminths (STHs), parasitic worms that damage their health and are a leading cause of maln
The yearly subscription-style payments made by NHS England to developers of novel antibiotics could be doubled from £10 million to £20 million in some cases, according to
The developer of a sensor designed to continuously monitor indoor spaces for pathogens that could cause pandemics has been given a €500,000 prize by Germany’s Merck KGaA i
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.